| 18th Jan 2022 7:00 am |
PRN |
Strategic Research Collaboration |
| 20th Dec 2021 12:49 pm |
PRN |
Director/PDMR Shareholding |
| 13th Dec 2021 3:55 pm |
PRN |
Director/PDMR Shareholding |
| 23rd Nov 2021 7:00 am |
PRN |
Joint Development Agreement with Leucid Bio |
| 30th Sep 2021 7:00 am |
PRN |
Half-year Report |
| 28th Sep 2021 7:00 am |
PRN |
Development of GMP Manufacturing Capacity |
| 4th Aug 2021 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 4th Aug 2021 4:35 pm |
RNS |
Price Monitoring Extension |
| 23rd Jul 2021 3:39 pm |
PRN |
Further re Conversion to UK PLC |
| 21st Jul 2021 7:00 am |
PRN |
Conversion to UK PLC |
| 1st Jul 2021 4:09 pm |
PRN |
Director/PDMR Shareholding |
| 30th Jun 2021 12:50 pm |
PRN |
Result of AGM |
| 22nd Jun 2021 7:00 am |
PRN |
Application filed for protected linearised synthetic DNA |
| 18th Jun 2021 7:00 am |
PRN |
Annual General Meeting 2021 |
| 4th Jun 2021 7:00 am |
PRN |
Notice of AGM and Posting of Accounts |
| 3rd Jun 2021 7:00 am |
PRN |
Final Results |
| 27th Apr 2021 7:00 am |
PRN |
Evaluation licence for muscular dystrophy vector |
| 26th Feb 2021 7:00 am |
PRN |
Director/PDMR Shareholding |
| 25th Feb 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 25th Feb 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 22nd Feb 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 22nd Feb 2021 9:31 am |
PRN |
Holding(s) in Company |
| 19th Feb 2021 5:35 pm |
PRN |
Holding(s) in Company |
| 19th Feb 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 19th Feb 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 17th Feb 2021 7:00 am |
PRN |
Admission to Trading on AIM and First Day of Dealings |
